| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.4 | 0.1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.7 | 0.1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.1 |